Our conference will convene leaders from across biotech, pharma, and the investment community to explore the full lifecycle of innovation, from early discovery through commercialization and funding. With a strong emphasis on the current investment landscape, translational science, and the challenges and opportunities in bringing novel therapies to market, we aim to foster meaningful dialogue among researchers, entrepreneurs, and investors.